Meenu Chhabra - Feb 23, 2022 Form 4 Insider Report for Vallon Pharmaceuticals, Inc. (GRI)

Role
Director
Signature
/s/ David Baker, attorney-in-fact
Stock symbol
GRI
Transactions as of
Feb 23, 2022
Transactions value $
$115,050
Form type
4
Date filed
3/9/2022, 04:02 PM
Next filing
Aug 8, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GRI Stock Option (Right to Buy) Award $115K +15K $7.67 15K Feb 23, 2022 Common Stock 15K $7.67 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reported late due to administrative error.
F2 This stock options vests in 24 equal monthly installments such that the stock options shall be fully vested as of the second annual anniversary of the date of grant.